Boothbay Fund Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,708
| Closed | -$1.34M | – | 1964 |
|
|
2021
Q1 | $1.34M | Buy |
1,708
+857
| +101% | +$670K | 0.05% | 380 |
|
|
2020
Q4 | $463K | Hold |
851
| – | – | 0.02% | 650 |
|
|
2020
Q3 | $390K | Hold |
851
| – | – | 0.02% | 623 |
|
|
2020
Q2 | $524K | Sell |
851
-874
| -51% | -$538K | 0.04% | 478 |
|
|
2020
Q1 | $820K | Buy |
1,725
+614
| +55% | +$292K | 0.07% | 296 |
|
|
2019
Q4 | $644K | Buy |
1,111
+124
| +13% | +$71.9K | 0.06% | 363 |
|
|
2019
Q3 | $650K | Sell |
987
-998
| -50% | -$657K | 0.06% | 339 |
|
|
2019
Q2 | $1.54M | Buy |
1,985
+1,520
| +327% | +$1.18M | 0.14% | 141 |
|
|
2019
Q1 | $328K | Buy |
+465
| New | +$328K | 0.03% | 392 |
|
|
2018
Q3 | – | Sell |
-611
| Closed | -$421K | – | 857 |
|
|
2018
Q2 | $421K | Buy |
+611
| New | +$421K | 0.04% | 278 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 725 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 798 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 888 |
|